Scollr summary
What this paper is about
The first dynamic pharmacokinetic data on cefepime/enmetazobactam penetration into the CNS is presented, offering a quantitative foundation for optimising dosing strategies for cefepime/enmetazobactam in the management of CNS infections caused by ESBL-producing Enterobacterales.
Full abstract
Read the full abstract
Background Central nervous system (CNS) infections caused by ESBL-producing Enterobacterales are associated with high morbidity and risk of therapeutic failure. While several newer β-lactam/β-lactamase inhibitor combinations have shown encouraging activity against gram-negative CNS infections, pharmacokinetic data for cefepime/enmetazobactam from the CNS have not previously been described. Methods Microdialysis was employed to quantify the unbound concentrations of cefepime and enmetazobactam following intravenous administration. Microdialysis catheters were placed in three CNS compartments: The medulla spinalis, the subarachnoid space, and the epidural space. Sixteen pigs were randomised to receive either a short-term infusion of cefepime/enmetazobactam (2 g/0.5 g over 2 h) or continuous infusion (initial dosage of 1 g/0.5 g administered over 15 min followed by 1 g/0.25 g over 7 h and 45 min) during three 8 h dosing intervals. Microdialysis and plasma samples were collected during the first (0-8 h) and third (16-24 h) dosing interval and quantified by LC–MS/MS. Pharmacokinetic target attainment was evaluated as the percentage of the dosing interval during which concentrations exceeded clinically relevant pharmacokinetic targets for Enterobacterales; 4 mg/L for Cefepime (T>MIC4) and 2 mg/L for enmetazobactam (T>Cthreshold2). Results All pigs completed the study, and data from 44/48 catheters were collected. For cefepime: In all compartments, regardless of administration, the mean T>MIC4 ranged from 98-100% and 97-100% for the first and third dosing interval, respectively. For enmetazobactam: In the first dosing interval, the mean T>Cthreshold2 ranged from 82-99% (short-term infusion) and 96-100% (continuous infusion) across all compartments. In the third dosing interval, the mean T>Cthreshold2 ranged from 85-100% (short-term infusion), and from 89-100% (continuous infusion) across all compartments. Conclusions This study presents the first dynamic pharmacokinetic data on cefepime/enmetazobactam penetration into the CNS. High T>MIC and T>Cthreshold target attainments were achieved in the medulla spinalis, the subarachnoid space and the epidural space, irrespective of mode of administration. These novel findings offer a quantitative foundation for optimising dosing strategies for cefepime/enmetazobactam in the management of CNS infections caused by ESBL-producing Enterobacterales.
Direct answer
What can I do from this paper page?
Use this page to scan "DYNAMIC ASSESSMENT OF CEFEPIME/ENMETAZOBACTAM CONCENTRATIONS IN MEDULLA SPINALIS, THE SUBARACHNOID AND EPIDURAL SPACE: AN EXPERIMENTAL PORCINE STUDY" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Antibiotics Pharmacokinetics and Efficacy research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Nielsen2026DYNAMIC,
title = {DYNAMIC ASSESSMENT OF CEFEPIME/ENMETAZOBACTAM CONCENTRATIONS IN MEDULLA SPINALIS, THE SUBARACHNOID AND EPIDURAL SPACE: AN EXPERIMENTAL PORCINE STUDY},
author = {Maria Bech Damsgaard Nielsen and Mads Kristian Duborg Mikkelsen and Hans Christian Rasmussen and Magnus Andreas Hvistendahl and Josefine Slater and Kresten Wendell Rickers and Haisheng Li and Christoph Crocoll and Michal Poborsky and Nis Pedersen Jørgensen and Alex Soriano and Maiken Stilling and Mats Bue},
journal = {Orthopaedic Proceedings},
year = {2026},
doi = {10.1302/1358-992x.2026.11.047},
url = {https://doi.org/10.1302/1358-992x.2026.11.047}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Antibiotics Pharmacokinetics and Efficacy research papers?
Follow Antibiotics Pharmacokinetics and Efficacy research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for DYNAMIC ASSESSMENT OF CEFEPIME/ENMETAZOBACTAM CONCENTRATIONS IN MEDULLA SPINALIS, THE SUBARACHNOID AND EPIDURAL SPACE: AN EXPERIMENTAL PORCINE STUDY. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app